Commentary on: Efficacy, Security, and Manageability of Gelified Hemostatic Matrix in Bleeding Control during Thoracic and Lumbar Spine Surgery: FloSeal vs Surgiflo

J Neurol Surg A Cent Eur Neurosurg 2016; 77(02): 143-145
DOI: 10.1055/s-0035-1566113

Georg Thieme Verlag KG Stuttgart · New York

Roberto Gazzeri

¹Department of Neurosurgery, San Giovanni Addolorata Hospital, Rome, Italy

References
1 Landi A, Gregori F, Marotta N, Delfini R. Efficacy, security, and manageability of gelified hemostatic matrix in bleeding control during thoracic and lumbar spine surgery: FloSeal versus Surgiflo. J Neurol Surg A Cent Eur Neurosurg 2015. In Press. DOI 10.1055/s-0035-1558413
2 Gazzeri R, Galarza M, Alfier A. Safety biocompatibility of gelatin hemostatic matrix (FloSeal and Surgiflo) in neurosurgical procedures. Surg Technol Int 2012; 22: 49-54
3 Gazzeri R, Galarza M, Neroni M, Alfieri A, Giordano M. Hemostatic matrix sealant in neurosurgery: a clinical and imaging study. Acta Neurochir (Wien) 2011; 153 (1) 148-154 ; discussion 155
4 Gazzeri R, De Bonis C, Galarza M. Use of a thrombin-gelatin hemostatic matrix (Surgiflo) in spinal surgery. Surg Technol Int 2014; 25: 280-285
5 Renkens Jr KL, Payner TD, Leipzig TJ , et al. A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine 2001; 26 (15) 1645-1650
6 Gazzeri R, Galarza M, Neroni M, Alfieri A, Esposito S. Minimal craniotomy and matrix hemostatic sealant for the treatment of spontaneous supratentorial intracerebral hemorrhage. J Neurosurg 2009; 110 (5) 939-942